• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的临床和组织学特征

[Clinical and histological features of non-alcoholic fatty liver disease].

作者信息

Shi Jun-ping, Xun Yun-hao, Hu Chen-bo, Zhang Li, Liu Hong, Lou Guo-qiang, Fan Jian-gao

机构信息

Hangzhou Sixth Hospital, Zhejiang University of Traditional Chinese Medicine, Hangzhou 310014, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6.

PMID:19958638
Abstract

OBJECTIVE

To investigate the clinical and histological features in Chinese patients with non-alcoholic fatty liver disease (NAFLD).

METHODS

108 patients with biopsy-proven NAFLD were enrolled in this study. Clinical, demographic, and biochemical data were compared between NAFLD patients with abnormal ALT and those with normal ALT.

RESULTS

Simple fatty liver, nonalcoholic steatohepatitis(NASH) and cirrhosis were diagnosed in 49 (45.4%), 57(52.7%) and 2 (1.9%) patients, respectively. ALT and AST levels of NASH group were higher than those of simple fatty liver group (t = 2.55, 3.13; P = 0.01, 0.00). Fifty of the 77 patients (64.9%) with abnormal ALT levels were diagnosed as non-alcoholic steatohepatitis (NASH), and twenty-six were diagnosed as simple fatty liver, according to liver histology. Among the 31 patients with normal ALT levels, nine (29%) had NASH and twenty-two had simple fatty liver (P = 0.00). The patients with normal ALT had lower necroinflammatory grade than patients with abnormal ALT (x2 = 10.30, P = 0.01), but they had similar degree of steatosis and fibrosis (x2 = 5.52, 6.12; P = 0.12, 0.01). AST, g-glutamyltransferase, total cholesterol, apolipoprotein A1, apolipoprotein B and systolic blood pressure of patients with normal ALT were all lower than those of patients with abnormal ALT (t = 5.91, 2.00, 2.30, 2.10, 3.14, 2.43; P = 0.00, 0.05, 0.02, 0.04, 0.00, 0.02), while spleen thickness and AST/ALT ratio in patients with normal ALT were higher than those with abnormal ALT significantly (t = 3.70, 2.95; P = 0.00, 0.01). Multivariate analysis revealed that ALT (OR = 2.78, 95% CI 1.06-7.3, P = 0.04) was the only independent predictor of NASH, and ALT had low accuracy in predicting NASH, the area under the receiver operating characteristics curves of ALT to predict NASH was 0.69 (95% CI 0.59-0.8, P = 0.00).

CONCLUSION

NAFLD patients have higher ALT level, and elevated serum level of ALT is independent predictor of the degree of inflammation, but not of steatosis and fibrosis.

摘要

目的

探讨中国非酒精性脂肪性肝病(NAFLD)患者的临床和组织学特征。

方法

本研究纳入108例经活检证实为NAFLD的患者。比较了谷丙转氨酶(ALT)异常和正常的NAFLD患者的临床、人口统计学和生化数据。

结果

分别有49例(45.4%)、57例(52.7%)和2例(1.9%)患者被诊断为单纯性脂肪肝、非酒精性脂肪性肝炎(NASH)和肝硬化。NASH组的ALT和谷草转氨酶(AST)水平高于单纯性脂肪肝组(t = 2.55,3.13;P = 0.01,0.00)。根据肝脏组织学检查,77例ALT异常的患者中有50例(64.9%)被诊断为非酒精性脂肪性肝炎(NASH),26例被诊断为单纯性脂肪肝。在31例ALT水平正常的患者中,9例(29%)患有NASH,22例患有单纯性脂肪肝(P = 0.00)。ALT正常的患者坏死性炎症分级低于ALT异常的患者(x2 = 10.30,P = 0.01),但他们的脂肪变性和纤维化程度相似(x2 = 5.52,6.12;P = 0.12,0.01)。ALT正常患者的AST、γ-谷氨酰转移酶、总胆固醇、载脂蛋白A1、载脂蛋白B和收缩压均低于ALT异常患者(t = 5.91,2.00,2.30,2.10,3.14,2.43;P = 0.00,0.05,0.02,0.04,0.00,0.02),而ALT正常患者的脾脏厚度和AST/ALT比值显著高于ALT异常患者(t = 3.70,2.95;P = 0.00,0.01)。多因素分析显示,ALT(OR = 2.78,95%可信区间1.06 - 7.3,P = 0.04)是NASH的唯一独立预测因素,且ALT预测NASH的准确性较低,ALT预测NASH的受试者工作特征曲线下面积为0.69(95%可信区间0.59 - 0.8,P = 0.00)。

结论

NAFLD患者ALT水平较高,血清ALT水平升高是炎症程度的独立预测因素,但不是脂肪变性和纤维化的预测因素。

相似文献

1
[Clinical and histological features of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的临床和组织学特征
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6.
2
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
3
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.简单的非侵入性纤维化评分系统可以可靠地排除非酒精性脂肪性肝病患者的晚期纤维化。
Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.
4
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.不同血清丙氨酸氨基转移酶水平的非酒精性脂肪性肝病患者的代谢和组织学特征。
Aliment Pharmacol Ther. 2009 Feb 15;29(4):387-96. doi: 10.1111/j.1365-2036.2008.03896.x. Epub 2008 Nov 17.
5
[Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].[一组病态肥胖患者中非酒精性脂肪性肝炎(NASH)的形态学诊断与肝功能检查之间的关系]
Rev Invest Clin. 2005 Jul-Aug;57(4):505-12.
6
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).丙氨酸氨基转移酶水平对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎(NASH)和肝纤维化的预测价值。
Liver Int. 2013 Oct;33(9):1398-405. doi: 10.1111/liv.12226. Epub 2013 Jun 13.
7
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.非酒精性脂肪性肝病患者转氨酶水平正常时发生严重肝病的风险:胰岛素抵抗和糖尿病的作用
Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.
8
The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.天冬氨酸氨基转移酶与丙氨酸氨基转移酶的比值:在区分非酒精性脂肪性肝炎与酒精性肝病中的潜在价值。
Am J Gastroenterol. 1999 Apr;94(4):1018-22. doi: 10.1111/j.1572-0241.1999.01006.x.
9
One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.一项为期一年的强化营养咨询对非酒精性脂肪性肝炎患者的组织学改善效果:一项试点研究。
Am J Gastroenterol. 2005 May;100(5):1072-81. doi: 10.1111/j.1572-0241.2005.41334.x.
10
Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者中区分非酒精性脂肪性肝炎与单纯性脂肪变性的临床模型
Liver Int. 2006 Mar;26(2):151-6. doi: 10.1111/j.1478-3231.2005.01209.x.

引用本文的文献

1
The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.腹腔镜袖状胃切除术和胃旁路手术对伊朗肥胖患者非酒精性脂肪性肝炎的影响。
Middle East J Dig Dis. 2021 Jul;13(3):200-207. doi: 10.34172/mejdd.2021.226. Epub 2021 May 11.
2
The Role of Elastography in Non-Alcoholic Fatty Liver Disease.弹性成像在非酒精性脂肪性肝病中的作用
Curr Health Sci J. 2020 Jul-Sep;46(3):255-269. doi: 10.12865/CHSJ.46.03.07. Epub 2020 Sep 30.
3
The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years.
组织学炎症对1年和3年内肝脏硬度值改善的影响。
J Clin Med. 2019 Nov 24;8(12):2065. doi: 10.3390/jcm8122065.
4
Nonalcoholic fatty liver disease: Diagnostic biomarkers.非酒精性脂肪性肝病:诊断生物标志物
World J Gastrointest Pathophysiol. 2017 May 15;8(2):11-26. doi: 10.4291/wjgp.v8.i2.11.
5
New Era for Usage of Serum Liver Enzymes as A Promising Horizon for the Prediction of Non-Alcoholic Fatty Liver Disease.血清肝酶用于预测非酒精性脂肪性肝病的新时代:前景广阔
Open Access Maced J Med Sci. 2016 Sep 15;4(3):348-352. doi: 10.3889/oamjms.2016.092. Epub 2016 Sep 1.
6
Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝纤维化的无创预测指标
World J Hepatol. 2011 Aug 27;3(8):219-27. doi: 10.4254/wjh.v3.i8.219.